Skip to main content

Table 2 Cohort characteristics

From: Acute kidney injury as an independent risk factor for unplanned 90-day hospital readmissions

 

90 day readmission or death (%)

90 day readmission free survival (%) baseline impairment

Univariable odds ratio (95% CI)

N

3065

 

13388

   

 Age (median, IQR)

74

(62–83)

69

(55–79)

1.20 (/10 years)

(1.17–1.23)

 Male sex

1372

(44.8)

5770

(43.1) ())

1.07

(0.99–1.16)

 Residential care

277

(9.0)

471

(3.5)

2.72

(2.34–3.18)

 Deprived (highest quintile)

298

(9.7)

1088

(8.1)

1.22

(1.06–1.39)

 Rural (settlement <3000)

735

(24.0)

3720

(27.8)

0.82

(0.75–0.90)

Admission context

 No admissions past yeara

1896

(61.9)

10461

(78.1)

1.38 (/admission)

(1.34–1.43)

  1 admission past year

593

(19.3)

1872

(14.0)

  

  2 admissions past year

244

(8.0)

620

(4.6)

  

  3+ admissions past year

332

(10.8)

435

(3.2)

  

 Length of stay (median, IQR)

7

(2–16)

3

(1–9)

1.05 (/7 days)

(1.04–1.06)

  Emergency admission

2326

(75.9)

7760

(58.0)

2.28

(2.09–2.50)

  Medical ward admission

1889

(61.6)

6570

(49.1)

1.67

(1.54–1.81)

  Intensive care admission

98

(3.2)

366

(2.7)

1.18

(0.94–1.47)

Renal function

 No AKI

2154

(70.3)

11676

(87.2)

(reference group)

 

 AKI stage 1

528

(17.2)

1190

(8.9)

2.41

(2.15–2.69)

 AKI stage 2

233

(7.6)

341

(2.5)

3.70

(3.12–4.40)

 AKI stage 3

150

(4.9)

181

(1.4)

4.49

(3.60–5.60)

 No prior AKI episodesa

2526

(82.4)

12188

(91.0)

1.71 (/episode)

(1.58–1.85)

  1 prior AKI episode

414

(13.5)

1000

(7.5)

  

  2+ prior AKI episodes

125

(4.1)

200

(1.5)

  

Baseline eGFR (median, IQR)a

63

(48–83)

66

(52–87)

0.94 (/10 ml/min/1.73 m2)

(0.93–0.96)

 Baseline eGFR 0–29

213

(6.9)

502

(3.7)

  

 Baseline eGFR 30–44

423

(13.8)

1461

(10.9)

  

 Baseline eGFR 45–59

713

(23.3)

3309

(24.7)

  

 Baseline eGFR ≥60

1716

(56.0)

8116

(60.6)

  

Discharge creatinine 20% > baseline

520

(17.0)

1167

(8.7)

2.14

(1.91–2.39)

Comorbidity

 Cancer

410

(13.4)

973

(7.3)

1.97

(1.74–2.23)

 Cardiac failure

317

(10.3)

592

(4.4)

2.49

(2.16–2.88)

 Cerebrovascular disease

231

(7.5)

580

(4.3)

1.80

(1.54–2.11)

 Dementia

96

(3.1)

163

(1.2)

2.62

(2.03–3.39)

 Diabetes

336

(11.0)

776

(5.8)

2.00

(1.75–2.29)

 Hemiplegia

28

(0.9)

71

(0.5)

1.73

(1.11–2.68)

 Liver disease

59

(1.9)

156

(1.2)

1.66

(1.23–2.25)

 Myocardial infarction

257

(8.4)

638

(4.8)

1.83

(1.57–2.13)

 Peptic ulcer disease

81

(2.6)

278

(2.1)

1.28

(1.00–1.64)

 Peripheral vascular disease

162

(5.3)

452

(3.4)

1.60

(1.33–1.92)

 Pulmonary disease

346

(11.3)

704

(5.3)

2.29

(2.00–2.62)

 Rheumatic disease

82

(2.7)

289

(2.2)

1.25

(0.97–1.60)

  1. Abbreviations: AKI acute kidney injury, CI confidence interval, eGFR estimated glomerular filtration rate, IQR inter-quartile range
  2. aModelled here linearly per 10 ml/min/1.73 m2 increase and reported in categories for clarity